Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
China
Sun Yat-sen Memorial Hospital, Guangzhou, Guandong The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Shanghai Ruijin Hospital, Shanghai Jiaotong University, Shanghai, Shanghai City